THOUSAND OAKS, Calif.,
March 16, 2017 /PRNewswire/
-- Amgen (NASDAQ:AMGN) will present at the Oppenheimer Global
Health Care Conference at 10:55 a.m.
ET on Tuesday, March 21, 2017,
in New York City. Sean E. Harper, M.D., executive vice president
of Research and Development at Amgen, and David W. Meline, executive vice president and
chief financial officer at Amgen, will present at the conference.
Live audio of the presentation can be accessed from the Events
Calendar on Amgen's website, www.amgen.com, under Investors. A
replay of the webcast will also be available on Amgen's website for
at least 90 days following the event.
About Amgen
Amgen is committed to unlocking the
potential of biology for patients suffering from serious illnesses
by discovering, developing, manufacturing and delivering innovative
human therapeutics. This approach begins by using tools like
advanced human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages
its expertise to strive for solutions that improve health outcomes
and dramatically improve people's lives. A biotechnology pioneer
since 1980, Amgen has grown to be one of the world's leading
independent biotechnology companies, has reached millions of
patients around the world and is developing a pipeline of medicines
with breakaway potential.
For more information, visit www.amgen.com and follow us on
www.twitter.com/amgen.
CONTACT: Amgen, Thousand
Oaks
Kristen Davis, 805-447-3008
(media)
Kristen Neese, 805-313-8267
(media)
Arvind Sood, 805-447-1060
(investors)
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/amgen-to-present-at-the-oppenheimer-global-health-care-conference-300425027.html
SOURCE Amgen